Basic Bladder Neurophysiology
Basic Bladder Neurophysiology
N e u ro p h y s i o l o g y
J. Quentin Clemens, MD, MSCI
KEYWORDS
Neuroanatomy Physiology Lower urinary tract
Pharmacology
Normal lower urinary tract function requires the low-pressure urine storage across a wide range
storage of urine at low intravesical pressure, of bladder volumes. This process is measured by
without leakage. Intermittently, this storage func- calculating the bladder compliance (change in
tion is interrupted by the voluntary and complete bladder volume/change in intravesical pressure),
expulsion of urine. These processes (storage and which is expressed in mL/cm H2O. Normal compli-
voiding) are unique in that they involve the coordi- ance is maintained throughout filling by reorienta-
nation of the peripheral autonomic, peripheral tion of the detrusor smooth muscle fibers and
somatic, and central nervous systems (CNS). connective tissue so that they are parallel to the
This article provides an overview of the basic prin- lumen, thinning of the lamina propria, and flat-
ciples that are recognized to regulate these func- tening of the urothelium.4 Bladder accommodation
tions, although many of these processes remain is a complex and poorly understood process that
poorly understood. Furthermore, much of this can be altered because of neurologic damage or
knowledge has been obtained from in vivo animal changes in the ECM content. For instance, an
models, and the relevance of these findings to increase in type III collagen has been found in
human physiology is not always clear. bladders with decreased compliance.5
Disclosures: Merck, stock ownership; Pfizer, consultant, investigator; Lilly, consultant; Afferent Pharmaceuti-
cals, consultant; Medtronic, proctor.
Division of Neurourology and Pelvic Reconstructive Surgery, Department of Urology, University of Michigan
Medical Center, 1500 East Medical Center Drive, Taubman Center 3875, Ann Arbor, MI 48109-5330, USA
E-mail address: [email protected]
fibers emerge from the cranial and sacral Preganglionic sympathetic efferent nerves exit
segments of the spinal cord, whereas sympathetic from the thoracolumbar segment of the spinal
fibers emerge from the thoracic and lumbar cord at T10 through L2. The ganglia for these
segments of the spinal cord. nerves have variable locations: some are next to
the vertebrae (paraganglia), some are between
CROSS-SECTIONAL ANATOMY OF THE the vertebrae and the target organ (preganglia),
SPINAL CORD and some are located with the end organ (periph-
eral ganglia).7 Sympathetic efferent nerves to the
Peripheral sensory information is carried via lower urinary tract are located within the hypogas-
afferent nerves fibers, which enter the dorsal tric nerve. The sympathetic efferent nerves modu-
(posterior) aspect of the spinal cord and then travel late contractions of the urethral smooth muscle
upward to the central processing centers in the and bladder outlet and inhibit parasympathetic
CNS (Fig. 1). Afferent cell bodies are located in activity that promotes bladder contraction. The
the dorsal root ganglia. The white matter of the primary neurotransmitter for postganglionic
spinal cord contains bundles of myelin-coated sympathetic fibers is norepinephrine, but the
neurons, whereas the gray matter contains the primary neurotransmitter for preganglionic sympa-
cell bodies of interneurons and efferent motor thetic fibers is ACh.
neurons. Within the gray matter, nerve cell bodies Preganglionic somatic efferent nerves exit from
are generally organized into functional clusters the sacral segment of the spinal cord at S2 through
called nuclei (such as Onuf nucleus). Axons within S4. Nerve bodies for these nerves are located in
the white matter are functionally grouped into the Onuf nucleus, along the lateral border of the
tracts. Efferent motor axons exit from the ventral ventral gray matter in the sacral region of the spinal
root of the spinal cord. cord. The nerve fibers travel within the pudendal
nerve to the external urethral sphincter, where
RELEVANT NEUROANATOMY: PNS AND they modulate striated (voluntary) sphincter
SPINAL CORD contraction.8
In humans and animals, afferent nerves have
Preganglionic parasympathetic efferent nerves been identified in the detrusor muscle and the sub-
exit from the sacral segment of the spinal cord at urothelium.9,10 The suburothelial afferent nerve
S2 through S4. The axons travel a long distance fibers form a plexus that lies immediately beneath
within the pelvic nerve to the ganglia (pelvic the urothelial lining, with some nerve terminals ex-
plexus) that are located immediately adjacent to tending into the urothelium itself. This plexus is
the end organ (bladder) (Fig. 2). These fibers more prominent in the trigone and bladder neck
modulate bladder contractions. The primary and relatively sparse in the bladder dome. Afferent
neurotransmitter for both pre- and postganglionic nerve fibers from the lower urinary tract travel
parasympathetic fibers is acetylcholine (ACh).6 within the pelvic, hypogastric, and pudendal
WHITE
MATTER
Motor
VENTRAL (Efferent) Out
Basic Bladder Neurophysiology 489
Fig. 2. Parasympathetic efferent nerves exit from the sacral region of the spinal cord at S2 through S4 and travel
within the pelvic nerve. Parasympathetic activity promotes bladder emptying by causing contraction of the de-
trusor and relaxation of the bladder outlet. Sympathetic efferent nerves exit from the thoracolumbar segment
of the spinal cord at T10 through L2 and travel within the hypogastric nerve. These nerves modulate contractions
of the urethral smooth muscle and bladder outlet and inhibit parasympathetic activity that promotes bladder
contraction. Somatic efferent nerves exit from the sacral segment of the spinal cord at S2 through S4 and travel
within the pudendal nerve to the external urethral sphincter, where they modulate striated (voluntary) sphincter
contraction. Afferent nerve fibers from the lower urinary tract travel within the pelvic, hypogastric, and pudendal
nerves. Therefore, these peripheral nerves carry bidirectional (afferent and efferent) information between the
end organs and the spinal cord.
nerves.11,12 Therefore, these peripheral nerves fibers appear to activate, become mechanosensi-
carry bidirectional (afferent and efferent) informa- tive, and modulate pathologic voiding reflexes.16
tion between the end organs and the spinal cord.
The sensory fibers enter the spinal cord via the RELEVANT NEUROANATOMY: BRAINSTEM
dorsal root, and the nerve cells bodies are located AND ABOVE
within the dorsal root ganglia. Afferent nerves
release numerous neurotransmitters (eg, Conclusive experimental evidence using brain-
substance P, neurokinins, calcitonin geneerelated lesioning techniques, electric stimulation, and
polypeptide, vasoactive intestinal polypeptide).13 axonal tracing studies indicate that an area of the
Most sensory innervation of the bladder and pons (the pontine micturition center [PMC] or Bar-
urethra originates in the thoracolumbar region of rington nucleus) mediates the normal micturition
the spinal cord and travels within the pelvic reflex by coordinating the activity of the detrusor
nerve.12 Within the pelvic nerve, 2 types of bladder and urethral sphincter muscles.17e20 Therefore,
afferent nerves have been identified, myelinated spinal cord lesions below this level often result in
Ad fibers and unmyelinated C fibers. The Ad fibers discoordination between the detrusor and urethral
respond to normal bladder distention and are sphincter (detrusor-sphincter dyssynergia). The
thought to be the primary functional afferent PMC receives input from multiple higher brain
nerves during normal micturition.12 Conversely, centers, including the basal ganglia, periaqueduc-
the C fibers respond to chemical irritation (noci- tal gray, thalamus, and hypothalamus.21 Brain
ception) or to cold, and most of these fibers are imaging studies in healthy volunteers suggest
inactive during normal micturition.14,15 However, a model of supraspinal bladder control, in which
during certain pathologic states (eg, inflammation, afferent signals from the lower urinary tract are
suprasacral spinal cord injury), these “silent” C received in the periaqueductal gray and relayed
490 Clemens
via the thalamus to the insula (which makes the by acetylcholinesterase. ACh is released from
sensations accessible to conscious awareness).22 postganglionic parasympathetic neurons, pregan-
According to this model, the cortex (via the ante- glionic autonomic neurons (sympathetic and para-
rior cingulate gyrus) monitors and controls micturi- sympathetic), and somatic neurons. Two main
tion reflexes and also makes voluntary voiding types of cholinergic receptors exist: nicotinic and
decisions (via the prefrontal cortex). muscarinic. Nicotinic receptors (which are respon-
sive to ACh and nicotine) are ligand-gated ion
NEURAL CONTROL OF THE LOWER URINARY channels and are found on the skeletal muscle
TRACT motor end plates, on the autonomic ganglia, and
in the CNS. The nicotinic receptors seem to have
During the storage phase of micturition, bladder a limited role in the control of micturition. Musca-
filling activates myelinated Ad afferent nerve fibers rinic receptors (which are responsive to ACh and
in the bladder wall. This afferent input results in muscarine) are G proteinecoupled receptors that
stimulation of sympathetic efferent activity (via activate ion channels via second-messenger
the hypogastric nerve), leading to contraction of cascades. These receptors are found on all auto-
smooth muscles in the bladder base and proximal nomic effector cells (eg, bladder, sweat glands,
urethra (via activation of a-adrenergic receptors) bowel) and in the CNS. Five subtypes of musca-
and relaxation of the detrusor (via activation of rinic receptors (M1 through M5) have been identi-
b-adrenergic receptors in the bladder body). fied, and the M2 and M3 subtypes predominate in
Somatic efferent activity (via the pudendal nerve) the bladder.28 Although M2 receptors are the
also increases, resulting in increased tone of the most plentiful in the detrusor (70% M2 vs 30%
striated external urethral sphincter. These M3 receptors), in vitro studies indicate that the
responses occur by spinal reflex pathways orga- M3 receptors are responsible for detrusor muscle
nized in the lumbosacral region of the spinal cord contraction.29e32 The functions of the detrusor
and represent guarding reflexes, which promote M2 receptors are less clear. Muscarinic receptors
continence.23e25 The parasympathetic system is are also found on presynaptic nerve terminals in
largely inactive during urine storage, which may the bladder and elsewhere, where they may play
partly be because of the sympathetic inhibition of a regulatory role via feedback inhibition.33,34
parasympathetic transmission at the ganglia level.
The voiding phase of micturition is initiated Excitation-contraction Coupling
voluntarily by signals from the cerebral cortex.
The initial event is relaxation of the striated Excitation-contraction coupling refers to the
external urethral sphincter, caused by inhibition process whereby binding of a ligand to a receptor
of somatic efferent activity. There is inhibition of causes force generation (muscle contraction)
sympathetic efferent activity, with concomitant (Fig. 3).35 In the detrusor smooth muscle, the
activation of parasympathetic outflow to the ligand is ACh and the receptor is the M3 receptor.
bladder and urethra.26 Bladder contraction is At rest, there is a very low concentration of free
mediated via muscarinic receptors in the bladder calcium ions (Ca21) in the smooth muscle cell.
body, and urethral smooth muscle relaxation is Binding of ACh to the M3 receptor triggers a G pro-
mediated through the release of nitric oxide teinemediated process, which causes Ca21
(NO).27 Maintenance of the voiding reflex is release from the sarcoplasmic reticulum as well
a complicated phenomenon that is mediated via as Ca21 influx from transmembrane ion channels.
communication between the spinal cord and the The free Ca21 binds to calmodulin, and the
pons (spinobulbospinal reflex), with the involve- Ca21-calmodulin complex then activates the
ment of midbrain structures such as the periaque- enzyme myosin light chain kinase, which phos-
ductal gray.21 phorylates the light chain of the contractile protein,
myosin. This phosphorylation causes the myosin
light chain to change shape and interact with actin,
PHARMACOLOGY OF THE LOWER URINARY
causing force generation.35 Alongside this
TRACT
process, alternate methods are at work to facilitate
Cholinergic Mechanisms
subsequent muscle relaxation. The Ca21-calmod-
In certain neurons of the CNS and PNS, the neuro- ulin complex activates transmembrane Ca21
transmitter ACh is synthesized from the essential pumps to remove free Ca21 from the cell, the
nutrient choline by the enzyme choline acetyltrans- ligand-receptor complex is degraded, and excess
ferase. In response to various stimuli, ACh is extracellular ACh is degraded by acetylcholines-
released into the synaptic cleft, where it either terase. This enzyme is abundant in the synaptic
binds to cholinergic receptors or is broken down cleft, and its role in rapidly clearing free ACh
Basic Bladder Neurophysiology 491
Nerve Terminal
ACh ACh
ACh
ACh
ACh ACh ACh ACh
Ca2+
ACh
G Protein M3 PLC
IP3 Ca2+
CONTRACTION
SR
Actin
Ca2+
MLCK
Ca2+
My osin
Calmodulin
Fig. 3. Excitation-contraction coupling. Ach is released from postganglionic parasympathetic nerve terminals into
the synaptic cleft, where it binds to the M3 receptor. This ligand-receptor complex triggers a cascade of signaling
events that involves a G protein, phospholipase C (PLC), and inositol triphosphate (IP3). This signaling cascade
leads to the release of free calcium (Ca21) into the cytosol by the sarcoplasmic reticulum (SR) as well as a direct
influx of Ca21 via transmembrane ion channels. The free Ca21 binds with calmodulin, and the resulting
Ca21-calmodulin complex activates the enzyme myosin light chain kinase (MLCK). The MLCK causes changes in the
structure of the myosin molecule, which allows the myosin to interact with actin, leading to a muscle contraction.
from the synapse is essential for proper muscle where they cause detrusor smooth muscle
function. relaxation.38
mechanisms exist, which at least partially mediate SENSORY ROLE OF THE UROTHELIUM
bladder contractions. In these nonhuman
mammals, there is good evidence that the trans- The urothelium has traditionally been viewed as
mitter responsible for the NANC component of a passive barrier that prevents passage of urinary
detrusor contraction is adenosine triphosphate toxins into the underlying bladder interstitium.
(ATP) acting on purinergic receptors.41,42 However, there is increasing evidence that the ur-
However, the component of NANC activation in othelium also has sensory and signaling properties
the normal human detrusor seems to be small. It that allow it communicate with nearby nerve and
is possible, however, that NANC mechanisms muscle tissue, suggesting that it is actively
may become more predominant in certain patho- involved in the storage and voiding phases of
logic states (eg, bladder outlet obstruction, over- micturition.50,51 For instance, the urothelium has
active bladder, neurogenic bladder, interstitial been shown to release chemical mediators (ATP,
cystitis).43,44 ACh, and NO) and to express numerous receptors
(eg, muscarinic, adrenergic, purinergic, and tachy-
Nitric Oxide kinin receptors).35,52 The mechanisms responsible
for urothelial ATP release have been the subject of
Stimulation of cholinergic receptors in the urethra considerable study because intravesical adminis-
causes contraction, rather than relaxation, of the tration of ATP induces detrusor overactivity and
urethral smooth muscle.45 Therefore, parasympa- mice deficient in the ATP receptor P2X3 exhibit
thetic pathways that promote voiding must elicit decreased voiding frequency and increased
urethral relaxation via noncholinergic mecha- bladder capacity.53,54 Therefore, further under-
nisms. Experimental studies indicate that NO, standing of these findings may provide additional
released from postganglionic parasympathetic therapeutic targets for lower urinary tract
nerves, is the major inhibitory neurotransmitter disorders.
that causes the urethral smooth muscle relaxation
during voiding.46,47 The mechanism of relaxation is
similar to that observed in corporal smooth muscle REFERENCES
(increased production of intracellular cyclic guano-
sine monophosphate and so forth). The functional 1. Elbadawi A, Schenk EA. Dual innervation of the
role of NO in the detrusor has not been mammalian urinary bladder, a histochemical study
established. of the distributions of cholinergic and adrenergic
nerves. Am J Anat 1966;119:405e27.
Vanilloids 2. Uvelius B. Length-tension relations of in vitro urinary
bladder smooth muscle strips. J Pharmacol Toxicol
Vanilloids are a class of compounds denoted by Methods 2001;45:87e90.
the presence of a vanillyl functional group. Two va- 3. Uvelius B, Gabella G. Relation between cell length
nilloids (capsaicin and resiniferatoxin [RTX]) are and force production in urinary bladder smooth
known to bind to receptors on C-fiber afferent muscle. Acta Physiol Scand 1980;110:357e65.
neurons. This binding causes desensitization, so 4. Chang SL, Chung JS, Yeung MK, et al. Roles of the
that the neurons no longer respond to stimuli. As lamina propria and the detrusor in tension transfer
discussed previously, C-fiber afferent neurons during bladder filling. Scand J Urol Nephrol Suppl
are considered to mediate pathologic bladder 1999;201:38e45.
reflexes. Therefore, intravesical treatment with 5. Landau EH, Jayanthi VR, Churchill BM, et al. Loss of
capsaicin and RTX has been examined as a poten- elasticity in dysfunctional bladders: urodynamic and
tial therapy for conditions such as neurogenic de- histochemical correlation. J Urol 1994;152:702e5.
trusor overactivity and interstitial cystitis.48,49 6. de Groat WC, Booth AM. Synaptic transmission in
pelvic ganglia. In: Maggi CA, editor. Nervous control
Additional Neurotransmitters and Receptors
of the urogenital system: the autonomic nervous
Multiple additional neurotransmitters and their system, vol. 3. London: Harwood Academic; 1993.
associated receptors have been found to be p. 291e347.
synthesized, stored, and released in the human 7. Kihara K, de Groat WC. Sympathetic efferent path-
lower urinary tract, including tachykinins (eg, ways projecting to the bladder neck and proximal
substance P, neurokinins), prostanoids (prosta- urethra in the rat. J Auton Nerv Syst 1997;62:
glandins and thromboxanes), and endothelins.13,35 134e42.
However, the functional roles of most of these 8. Thor KB, Morgan C, Nadelhaft I, et al. Organization
agents have not been established, and animal of afferent and efferent pathways in the pudendal
experiments suggest that these roles may vary nerve of the female cat. J Comp Neurol 1989;288:
across species. 263e79.
Basic Bladder Neurophysiology 493
9. Dixon JS, Gilpin CJ. Presumptive sensory axons of 26. de Groat WC. Organization of the sacral parasym-
the human urinary bladder: a fine structural study. pathetic reflex pathways to the urinary bladder and
J Anat 1987;151:199e207. large intestine. J Auton Nerv Syst 1981;3:135e60.
10. Gabella G, Davis C. Distribution of afferent axons in 27. Andersson KE. Pharmacology of lower urinary tract
the bladder of rats. J Neurocytol 1998;27:141e55. smooth muscles and penile erectile tissues. Phar-
11. Yoshimura N, de Groat WC. Neural control of the macol Rev 1993;45:253e308.
lower urinary tract. Int J Urol 1997;4:111e25. 28. Bschleipfer T, Schukowski K, Weidner W, et al.
12. Janig W, Morrison JFB. Functional properties of Expression and distribution of cholinergic receptors
spinal visceral afferents supplying abdominal and in the human urothelium. Life Sci 2007;80:2303e7.
pelvic organs, with special emphasis on visceral no- 29. Harriss DR, Marsh KA, Birmingham AT, et al. Expres-
ciception. Prog Brain Res 1986;67:87e114. sion of muscarinic M3 receptors coupled to inositol
13. Andersson KE. Bladder activation: afferent mecha- phospholipid hydrolysis in human detrusor smooth
nisms. Urology 2002;59(Suppl 5A):43e50. muscle cells. J Urol 1995;154:1241e5.
14. Habler HJ, Janig W, Koltzenburg M. Activation of 30. Yamaguchi O, Shishido K, Tamura K, et al. Evaluation
unmyelinated afferent fibres by mechanical stimuli of mRNAs encoding muscarinic receptor subtypes in
and inflammation of the urinary bladder in the cat. human detrusor muscle. J Urol 1996;156:1208e13.
J Physiol 1990;425:545e62. 31. Hegde SS, Choppin A, Bonhaus D, et al. Functional
15. Fall M, Lindstrom S, Mazieres L. A bladder-to- role of M2 and M3 muscarinic receptors in the
bladder cooling reflex in the cat. J Physiol 1990; urinary bladder of rats in vitro and in vivo. Br J Phar-
427:281e300. macol 1997;120:1409e18.
16. de Groat WC, Kawatani M, Hisamitsu T, et al. Mech- 32. Lai FM, Cobuzzi A, Spinelli W. Characterization of
anisms underlying the recovery of urinary bladder muscarinic receptors mediating the contraction of
function following spinal cord injury. J Auton Nerv the urinary detrusor muscle in cynomolgus monkeys
Syst 1990;30:S71e7. and guinea pigs. Life Sci 1998;62:1179e86.
17. Barrington FJ. The effects of lesions of the hind and 33. D’Agostino G, Bolognesi ML, Lucchelli A, et al. Pre-
midbrain on micturition in the cat. Q J Exp Physiol junctional muscarinic inhibitory control of acetylcho-
1925;15:81e102. line release in the human isolated detrusor:
18. Mallory BS, Roppolo JR, de Groat WC. Pharmaco- involvement of the M4 receptor subtype. Br J Phar-
logic modulation of the pontine micturition center. macol 2000;129:493e500.
Brain Res 1991;546:310e20. 34. Somogyi GT, de Groat WC. Evidence for inhibitory
19. Holstege G, Griffiths D, De Wall H, et al. Anatomical nicotinic and facilitatory muscarinic receptors in
and physiological observations on supraspinal cholinergic nerve terminals of the rat urinary
control of the bladder and urethral sphincter bladder. J Auton Nerv Syst 1992;37:89e97.
muscles in the cat. J Comp Neurol 1986;250: 35. Andersson KE, Arner A. Urinary bladder contraction
449e61. and relaxation: physiology and pathophysiology.
20. Nadelhaft I, Vera PL, Card JP, et al. Central nervous Physiol Rev 2004;84:935e86.
system neurons labeled following the injection of 36. Furuya S, Kumamoto Y, Yokoyama E, et al. Alpha-
pseudorabies virus into the rat urinary bladder. Neu- adrenergic activity and urethral pressure in prostatic
rosci Lett 1992;143:271e4. zone in benign prostatic hypertrophy. J Urol 1982;
21. Fowler CJ, Griffiths G, de Groat WC. The neural 128:836e9.
control of micturition. Nat Rev Neurosci 2008;9: 37. Nasu K, Moriyama N, Fukasawa R, et al. Quantifica-
453e66. tion and distribution of alpha-1 adrenoreceptor
22. Griffiths D, Tadic SD. Bladder control, urgency, and subtype mRNAs in human proximal urethra. Br J
urge incontinence: evidence from functional brain Pharmacol 1998;123:1289e93.
imaging. Neurourol Urodyn 2008;27:466e74. 38. Yamaguchi O. Beta 3-adrenoceptors in human de-
23. de Groat WC, Booth AM, Yoshimura N. Neurophysi- trusor muscle. Urology 2002;59(Suppl 1):25e9.
ology of micturition and its modification in animal 39. Johns A. Alpha- and beta-adrenergic and musca-
models of human disease. In: Maggi CA, editor. rinic cholinergic binding sites in the bladder and
Nervous control of the urogenital system: the auto- urethra of the rabbit. Can J Physiol Pharmacol
nomic nervous system, vol. 3. London: Harwood 1983;61:61e6.
Acadmeic Publishers; 1993. p. 227. 40. Levin RM, Ruggieri MR, Wein AJ. Identification of
24. de Groat WC, Vizzard MA, Araki I, et al. Spinal inter- receptor subtypes in the rabbit and human urinary
neurons and preganglionic neurons in sacral auto- bladder by selective radio-ligand binding. J Urol
nomic reflex pathways. Prog Brain Res 1996;107: 1988;139:844e8.
97e111. 41. Lee HY, Bardini M, Burnstock G. Distribution of P2X
25. Park JM, Bloom DA, McGuire EJ. The guarding receptors in the urinary bladder and the ureter of the
reflex revisited. Br J Urol 1997;80:940e5. rat. J Urol 2000;163:2002e7.
494 Clemens
42. O’Reilly BA, Kosaka AH, Chang TK, et al. 48. Fowler CJ, Beck R, Gerrard S, et al. Intravesi-
A quantitative analysis of purinoceptor expression cal capsaicin for treatment of detrusor hyperre-
in human fetal and adult bladders. J Urol 2001; flexia. J Neurol Neurosurg Psychiatry 1994;57:
165:1730e4. 169e73.
43. Bayliss M, Wu C, Newgreen D, et al. A quantitative 49. Payne CK, Mosbaugh PG, Forrest JB, et al. Intraves-
study of atropine-resistant contractile responses in ical resiniferatoxin for the treatment of interstitial
human detrusor smooth muscle from stable, unstable cystitis: a randomized, double-blind, placebo
and obstructed bladders. J Urol 1999;162:1833e9. controlled trial. J Urol 2005;173:1590e4.
44. Palea S, Artibani W, Ostardo E, et al. Evidence for 50. Apodaca G. The uroepithelium: not just a passive
purinergic neurotransmission in human urinary barrier. Traffic 2004;5:117e28.
bladder affected by interstitial cystitis. J Urol 1993; 51. Ferguson DR. Urothelial function. BJU Int 1999;84:
150:2007e12. 235e42.
45. Ek A. Innervation and receptor functions of the 52. Birder LA, de Groat WC. Mechanisms of disease
human urethra. Scand J Urol Nephrol Suppl 1977; involvement of the urothelium in bladder dysfunc-
45:1e50. tion. Nat Clin Pract Urol 2007;4:46e54.
46. Andersson KE, Garcia Pascual A, Persson K, et al. 53. Pandita RK, Andersson KE. Intravesical ATP stimu-
Electrically-induced, nerve-mediated relaxation of lates the micturition reflex in awake, freely moving
rabbit urethra involves nitric oxide. J Urol 1992; rats. J Urol 2002;168:1230e4.
147:253e9. 54. Cockayne DA, Hamilton SG, Zhu QM, et al. Urinary
47. Bennett BC, Kruse MN, Roppolo JR, et al. Neural bladder hyporeflexia and reduced pain-related
control of urethral outlet activity in vivo: role of nitric behaviour in P2X3-deficient mice. Nature 2000;
oxide. J Urol 1995;153:2004e9. 407:1011e5.